RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor
The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
Calcitonin-gene-related peptide (CGRP) and adrenomedullin are related peptides with distinct pharmacological profiles. Here we show that a receptor with seven transmembrane domains, the calcitonin-receptor-like receptor (CRLR), can function as either a CGRP receptor or an adrenomedullin receptor, depending on which members of a new family of single-transmembrane-domain proteins, which we have called receptor-activity-modifying proteins or RAMPs, are expressed. RAMPs are required to transport CRLR to the plasma membrane. RAMP1 presents the receptor at the cell surface as a mature glycoprotein and a CGRP receptor. RAMP2-transported receptors are core-glycosylated and are adrenomedullin receptors.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“For several years, CRLR was an”
From The Activity of Peptides of the Calcitonin Family in Bone (2019) · cites this paper as [146]
In the citing paper
“Dimerization of CRLR with RAMP1 forms a specific, highaffinity receptor for CGRP, whereas CRLR dimerization with either RAMP2 or RAMP3 produces receptors with high affinity to adrenomedullin (146).”
From The Activity of Peptides of the Calcitonin Family in Bone (2019) · cites this paper as [146]
In the citing paper
“CRLR by itself cannot function as a receptor for CGRP as it needs to form complexes with accessory proteins from the RAMP family134.”
From Neuropeptides Substance P and Calcitonin Gene Related Peptide Accelerate the Development and Fibrogenesis of Endometriosis (2019) · cites this paper as [134]
In the citing paper
“while for CGRP, its major receptors are calcitonin receptor like receptor (CRLR) and receptor activity modifying protein 1 (RAMP-1).”
From Neuropeptides Substance P and Calcitonin Gene Related Peptide Accelerate the Development and Fibrogenesis of Endometriosis (2019) · cites this paper as [134]
Citations
Cites
Ponath, P. D., Qin, S., Post, T. W., Wang, J., Wu, L., Gerard, N. P., Newman, W., Gerard, C., & Mackay, C. R. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.6.2437 · Cited by 612 · cited 1×
“Many receptors are not easily expressed in commonly used host cell lines: GABA b , eotaxin (CKR3”
BackgroundChang, C.-P., Pearse, R. V., O'Connell, S., & Rosenfeld, M. G. (1993) · Neuron · doi:10.1016/0896-6273(93)90230-o · Cited by 537
Teasdale, R. D., & Jackson, M. R. (1996) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.12.1.27 · Cited by 500 · cited 1×
“This pair of basic residues is similar to an endoplasmic-reticulum-retrieval moti”
BackgroundExpression Cloning of an Adenylate Cyclase-Coupled Calcitonin Receptor
Lin, H. Y., Harris, T. L., Flannery, M. S., Aruffo, A., Kaji, E. H., Gorn, A., Kolakowski, L. F., Lodish, H. F., & Goldring, S. R. (1991) · Science · doi:10.1126/science.1658940 · Cited by 451
A cDNA Encoding the Calcitonin Gene-related Peptide Type 1 Receptor
Aiyar, N., Rand, K., Elshourbagy, N. A., Zeng, Z., Adamou, J. E., Bergsma, D. J., & Li, Y. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.19.11325 · Cited by 320
Cloning and Expression of cDNA Encoding a Rat Adrenomedullin Receptor
Kapas, S., Catt, K. J., & Clark, A. J. L. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.43.25344 · Cited by 288 · cited 1×
“Two related members of the ‘family A’ class of GPCRs, RDC1 and G10D, were then identified as receptors for CGRP and ADM, respectivel”
BackgroundCalcitonin gene-related peptide: Multiple actions, multiple receptors
Poyner, D. R. (1992) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(92)90036-y · Cited by 225 · cited 1×
“These activities include the regulation of neuromuscular junctions, of antigen presentation within the immune system, of vascular tone and of sensory neurotransmissio”
BackgroundWang, X., Yue, T. L., Barone, F. C., White, R. F., Clark, R. K., Willette, R. N., Sulpizio, A. C., Aiyar, N. V., Ruffolo, R. R., & Feuerstein, G. Z. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.25.11480 · Cited by 191 · cited 1×
“and its messenger RNA is upregulated in CNS tissues that are subject to ischaemi”
BackgroundIdentification of an Orphan Receptor Gene as a Type 1 Calcitonin Gene-Related Peptide Receptor
Kapas, S., & Clark, A. J. L. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.2847 · Cited by 175
Muff, R., Born, W., & Fischer, J. A. (1995) · European Journal of Endocrinology · doi:10.1530/eje.0.1330017 · Cited by 155
Cited by
Items 801–900 of 1,009
Kuwasako, K., Cao, Y., Chu, C., Iwatsubo, S., Eto, T., & Kitamura, K. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m511147200 · Cited by 39
Identification of α 1L ‐adrenoceptor in mice and its abolition by α 1A ‐adrenoceptor gene knockout
Muramatsu, I., Morishima, S., Suzuki, F., Yoshiki, H., Anisuzzaman, A. S. M., Tanaka, T., Rodrigo, M. C., Myagmar, B., & Simpson, P. C. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.360 · Cited by 39
“This has been demonstrated in the receptor for calcitonin gene-related peptide, in which different phenotypes are produced by association with different receptormodifying proteins (McLatchie et al., 1998; Poyner et al., 2002).”
BackgroundAltmayr, F., Jusek, G., & Holzmann, B. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.066787 · Cited by 42
Intermedin Functions as a Pituitary Paracrine Factor Regulating Prolactin Release
Chang, C. L., Roh, J., Park, J., Klein, C., Cushman, N., Haberberger, R. V., & Hsu, S. Y. (2005) · Molecular Endocrinology · doi:10.1210/me.2004-0191 · Cited by 40
“• IMD Role in Regulation of Prolactin Release Mol Endocrinol, November 2005, 19(11):2824–2838 2831”
BackgroundInfluentialPetersen, K. A., Nilsson, E., Olesen, J., & Edvinsson, L. I. (2005) · Cephalalgia · doi:10.1111/j.1468-2982.2005.00869.x · Cited by 39
Yanagita, T., Yamamoto, R., Sugano, T., Kobayashi, H., Uezono, Y., Yokoo, H., Shiraishi, S., Minami, S., & Wada, A. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703500 · Cited by 40
“Although AM22± 52 is generally accepted as an antagonist for AM receptors (Eguchi et al., 1994; McLatchie et al., 1998), it is reported to suppress CGRP (but not AM)induced vascular dilation in cat hindlimb (Champion et al., 1997).”
BackgroundSams, A. G., & Jansen‐Olesen, I. (1998) · Neuroscience Letters · doi:10.1016/s0304-3940(98)00844-1 · Cited by 40
Calcitonin gene‐related peptide receptor expression in healthy and inflamed human pulp tissue
Caviedes‐Bucheli, J., Arenas, N., Guiza, O., Moncada, N. A., Moreno, G. C., Diaz, E., & Muñoz, H. R. (2005) · International Endodontic Journal · doi:10.1111/j.1365-2591.2005.01006.x · Cited by 38
A key role for tryptophan 84 in receptor activity-modifying protein 1 in the amylin 1 receptor
Gingell, J. J., Qi, T., Bailey, R. J., & Hay, D. L. (2010) · Peptides · doi:10.1016/j.peptides.2010.03.027 · Cited by 38
Seiler, K., Nusser, J. I., Lennerz, J. K., Neuhuber, W., & Meßlinger, K. (2013) · The Journal of Headache and Pain · doi:10.1186/1129-2377-14-74 · Cited by 38
“Since CLR and RAMP1 components are required for forming functional CGRP receptors [37] we conclude that the number of functional CGRP receptors may be upregulated after NO donor pretreatment.”
BackgroundSekiguchi, T., Kuwasako, K., Ogasawara, M., Takahashi, H., Matsubara, S., Osugi, T., Muramatsu, I., Sasayama, Y., Suzuki, N., & Satake, H. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.664003 · Cited by 41
“Mammalian CLR that is associated with RAMP reportedly elicits cAMP production in response to CGRP or adrenomedullin (8, 33, 34).”
BackgroundOhlsson, L., Haanes, K. A., Kronvall, E., Xu, C., Snellman, J., & Edvinsson, L. I. (2019) · Cephalalgia · doi:10.1177/0333102419867282 · Cited by 38
“showed that the CGRP-R consists of two subunits, the CLR and RAMP1 (15).”
BackgroundInfluentialRecent Advances in Structure and Function Studies on Human Bitter Taste Receptors
Pydi, S. P., Upadhyaya, J. D., Singh, N., Bhullar, R. P., & Chelikani, P. (2012) · Current Protein and Peptide Science · doi:10.2174/138920312803582942 · Cited by 40
“Accessory proteins such as receptor activity modifying proteins (RAMPs), receptor expression enhancing protein (REEP), and receptor transporting protein (RTP) recognize and bind to specific sequences on GPCRs, and promote cell surface expression by different mechanisms, including masking of ER retention motifs [36, 38…”
BackgroundDong, Y.-L., Reddy, D. M., Green, K. E., Chauhan, M., Wang, H.-Q., Nagamani, M., Hankins, G. D. V., & Yallampalli, C. (2007) · Biology of Reproduction · doi:10.1095/biolreprod.106.059089 · Cited by 40
“It has been reported that CALCRL functions as a receptor for three ligands, CALCA, adrenomedullin (ADM), and intermedin (ADM 2 ), in the presence of its receptor activity modifying proteins (RAMP1, RAMP2, and RAMP3) [14].”
InfluentialMorara, S., Rosina, A., Provini, L., Forloni, G., Caretti, A., & Wimalawansa, S. J. (2000) · Neuroscience · doi:10.1016/s0306-4522(00)00276-1 · Cited by 38
Wang, X., Nishikimi, T., Akimoto, K., Tadokoro, K., Mori, Y., & Minamino, N. (2003) · Journal of Hypertension · doi:10.1097/00004872-200306000-00018 · Cited by 38
Adrenomedullin and related peptides: receptors and accessory proteins
Muff, R., Born, W., & Fischer, J. A. (2001) · Peptides · doi:10.1016/s0196-9781(01)00515-0 · Cited by 43
Adrenomedullin—a regulator of bone formation
Cornish, J., Naot, D., & Reid, I. R. (2003) · Regulatory Peptides · doi:10.1016/s0167-0115(03)00025-9 · Cited by 41
Katafuchi, T., Yasue, H., Osaki, T., & Minamino, N. (2009) · Peptides · doi:10.1016/j.peptides.2009.06.012 · Cited by 37
Whiting, L., McCutcheon, J. E., Boyle, C. N., Roitman, M. F., & Lutz, T. A. (2017) · Physiology & Behavior · doi:10.1016/j.physbeh.2017.03.023 · Cited by 37
Advances in Understanding the Initial Steps of Pruritoceptive Itch: How the Itch Hits the Switch
Kahremany, S., Hofmann, L., Gruzman, A., & Cohen, G. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21144883 · Cited by 37
Hay, D. L., Harris, P. W. R., Kowalczyk, R., Brimble, M. A., Rathbone, D. L., Barwell, J., Conner, A. C., & Poyner, D. R. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12464 · Cited by 35
“The CT receptor complexes with RAMPs to give the AMY1, AMY2 and AMY3 receptors for amylin (McLatchie et al., 1998; Christopoulos et al., 1999; Muff et al., 1999); these exist as either (a) or (b) forms depending on the splice variant of CT receptor that is involved (Poyner et al., 2002).”
BackgroundMoore, E. L., Gingell, J. J., Kane, S. A., Hay, D. L., & Salvatore, C. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.02.131 · Cited by 37
“This is comprised of two membrane-spanning proteins, calcitonin receptor-like receptor (CLR), and receptor activity modifying protein 1 (RAMP1) [11].”
BackgroundThompson, B. J., Washington, M. K., Kurre, U., Singh, M., Rula, E. Y., & Emeson, R. B. (2007) · Digestive Diseases and Sciences · doi:10.1007/s10620-007-9848-7 · Cited by 40
Increased Expression of Adrenomedullin 2/Intermedin in Rat Hearts with Congestive Heart Failure
Hirose, T., Totsune, K., Mori, N., Morimoto, R., Hashimoto, M., 中繁由紀子, Metoki, H., Asayama, K., Kikuya, M., Ohkubo, T., et al. (2008) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2008.06.020 · Cited by 37
“CGRP, AM and AM2/IMD activate the complex of calcitonin receptor-like receptor (CRLR) and one of the three types of receptor activity-modifying proteins (RAMPs) to transfer their signals [1,2,7].”
BackgroundJulián, M., Cacho, M., García, M. A., Martín‐Santamaría, S., de Pascual‐Teresa, B., Ramos, A., Martínez, A., & Cuttitta, F. F. (2005) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2004.10.016 · Cited by 43
Wang, Y., Kaminski, N. E., & Wang, D. H. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.112904 · Cited by 37
“RAMPs are required to transport CRLR to the plasma membrane, determining its glycosylation state, and defining its pharmacological properties (McLatchie et al., 1998).”
BackgroundAdrenomedullin receptor binding sites in rat brain and peripheral tissues
Juanéda, C., Dumont, Y., Chabot, J., Fournier, A., & Quirion, R. (2003) · European Journal of Pharmacology · doi:10.1016/s0014-2999(03)02042-9 · Cited by 42
G Protein-Coupled Receptors: What a Difference a ‘Partner’ Makes
Roux, B. T., & Cottrell, G. S. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms15011112 · Cited by 40
“ligand binding specificity [80]”
Hasbak, P., Sams, A. G., Schifter, S., Longmore, J., & Edvinsson, L. I. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704210 · Cited by 39
“Expression and formation of CGRP- and AM receptors are therefore possible (Mclatchie et al., 1998).”
BackgroundLigand binding and activation of the CGRP receptor
Conner, A. C., Simms, J., Barwell, J., Wheatley, M., & Poyner, D. R. (2007) · Biochemical Society Transactions · doi:10.1042/bst0350729 · Cited by 49
Young, A. (2005) · Advances in pharmacology · doi:10.1016/s1054-3589(05)52003-9 · Cited by 39
Hagner, S., Haberberger, R. V., Kummer, W., Springer, J., Fischer, A., Böhm, S. K., Göke, B., & McGregor, G. P. (2001) · Neuropeptides · doi:10.1054/npep.2000.0844 · Cited by 37
“Adrenomedullin exhibits a selective high af®nity for the receptor that is dependent on the coexpression of speci®c subtypes of the RAMP proteins which are mandatory for CGRPR-1 function as well as determining ligand speci®city (Foord and Marshall, 1999; McLatchie et al., 1998).”
Pharmacological evidence for CGRP uptake into perivascular capsaicin sensitive nerve terminals
Sams, A. G., Ørskov, C., & Jansen‐Olesen, I. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703910 · Cited by 37
“As CGRP receptors are coupled to adenylate cyclase (Aiyar et al., 1996; McLatchie et al., 1998), it was investigated, whether the CGRP-release upon the fourth capsaicin stimulation, could be mimicked if the preceding CGRP-incubation was substituted by incubation with a direct activator of adenylate…”
BackgroundMethodKoo, D. J., Yoo, P. S., Cioffi, W. G., Bland, K. I., Chaudry, I. H., & Wang, P. (2000) · Journal of Surgical Research · doi:10.1006/jsre.2000.5916 · Cited by 39
Willi, M., Yoo, K. H., Reinisch, F., Kuhns, T. M., Lee, H., Wang, C., & Hennighausen, L. G. (2017) · Nature Communications · doi:10.1038/ncomms16069 · Cited by 37
Grieco, P., & Gomez-Monterrey, I. M. (2018) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2018.11.021 · Cited by 37
Amplification and Adaptation in the Ethylene Signaling Pathway
Azhar, B. J., Zulfiqar, A., Shakeel, S. N., & Schaller, G. E. (2019) · Small Methods · doi:10.1002/smtd.201900452 · Cited by 39
Glüxam, T., Grandits, A. M., Schlerka, A., Nguyen, C. H., Etzler, J., Finkes, T., Fuchs, M., Scheid, C., Heller, G., Hackl, H., et al. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20235826 · Cited by 39
“Co-expression of one of three single transmembrane domain coreceptors, namely, receptor activity modifying protein (RAMP) 1, RAMP2, or RAMP3, is required both for its expression at the cell surface and binding of its peptide ligands [2].”
BackgroundClark, A., Mullooly, N., Safitri, D., Harris, M., de Vries, T., MaassenVanDenBrink, A., Poyner, D. R., Gianni, D., Wigglesworth, M. J., & Ladds, G. (2021) · Communications Biology · doi:10.1038/s42003-021-02293-w · Cited by 36
Structure–function relationships of the N‐terminus of receptor activity‐modifying proteins
Qi, T., & Hay, D. L. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00541.x · Cited by 36
Kokkoris, S., Andrews, P., & Webb, D. J. (2012) · Frontiers in Endocrinology · doi:10.3389/fendo.2012.00135 · Cited by 38
“However, they are not CGRP receptors by themselves (McLatchie et al., 1998; Sexton et al., 2009).”
BackgroundInfluentialFève, M., Saliou, J., Zeniou, M., Lennon, S., Carapito, C., Dong, J., DORSSELAER, A. V., Junier, M., Chneiweiss, H., Cianférani, S., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0091519 · Cited by 38
“It functions either as a receptor for calcitonin-gene-related peptide (CGRP) when associated to RAMP1 or for adrenomodullin (AM) when associated to RAMP2 or RAMP3 [159].”
BackgroundMoad, H. E., & Pioszak, A. A. (2013) · Protein Science · doi:10.1002/pro.2377 · Cited by 35
“CGRP(8-37)NH2 did not bind the tethered AM receptor ECD fusion in the competition assay [Fig.”
BackgroundMethodInfluentialDesensitisation of adrenomedullin and CGRP receptors
Hay, D. L., Poyner, D. R., & Smith, D. M. (2003) · Regulatory Peptides · doi:10.1016/s0167-0115(03)00032-6 · Cited by 36
Mishima, K., Kato, J., Kuwasako, K., Ito, K., Imamura, T., Kitamura, K., & Eto, T. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.5572 · Cited by 36
Tilakaratne, N., & Sexton, P. M. (2005) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2005.04295.x · Cited by 43
Bicknell, A. B., Lomthaisong, K., Gladwell, R. T., & Lowry, P. J. (2000) · Journal of Neuroendocrinology · doi:10.1046/j.1365-2826.2000.00543.x · Cited by 38
The cloned guinea pig neuropeptide Y receptor Y1 conforms to other mammalian Y1 receptors
Berglund, M. M., Holmberg, S. K. S., Eriksson, H., Gedda, K., Maffrand, J., Gal, C. S., Chhajlani, V., Grundemar, L., & Larhammar, D. (1999) · Peptides · doi:10.1016/s0196-9781(99)00098-4 · Cited by 36
The satiating hormone amylin enhances neurogenesis in the area postrema of adult rats
Liberini, C. G., Borner, T., Boyle, C. N., & Lutz, T. A. (2016) · Molecular Metabolism · doi:10.1016/j.molmet.2016.06.015 · Cited by 37
RAMP1 signaling improves lymphedema and promotes lymphangiogenesis in mice
Mishima, T., Ito, Y., Nishizawa, N., Amano, H., Tsujikawa, K., Miyaji, K., Watanabe, M., & Majima, M. (2017) · Journal of Surgical Research · doi:10.1016/j.jss.2017.05.124 · Cited by 37
Hinrichs, S., Scherschel, K., Krüger, S., Neumann, F., Schwarzl, M., Yan, I., Warnke, S., Ojeda, F., Zeller, T., Karakas, M., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1721635115 · Cited by 37
“In particular, the dimer CALCRL/RAMP2 is described as ADM1 receptor, whereas CALCRL and RAMP3 form the ADM2 receptor (18).”
BackgroundCalcitonin Gene Related Family Peptides: Importance in Normal Placental and Fetal Development
Yallampalli, C., Chauhan, M., Endsley, J. J., & Sathishkumar, K. (2014) · Advances in experimental medicine and biology · doi:10.1007/978-1-4939-1031-1_20 · Cited by 35
Cottrell, G. S., Alemi, F., Kirkland, J. G., Grady, E. F., Corvera, C. U., & Bhargava, A. (2012) · Peptides · doi:10.1016/j.peptides.2012.03.020 · Cited by 39
“RAMPs are a family of three single transmembrane proteins required to chaperone CLR from intracellular organelles to the cell surface and to effect CLR terminal glycosylation and peptide specificity [17, 21].”
BackgroundGlowka, T. R., Steinebach, A., Stein, K., Schwandt, T., Lysson, M., Holzmann, B., Tsujikawa, K., de Jonge, W. J., Kalff, J. C., & Wehner, S. (2015) · Neurogastroenterology & Motility · doi:10.1111/nmo.12584 · Cited by 37
Deville, J., Bartoli, C., Berenguer‐Daizé, C., Fernandez-Sauze, S., Kaafarani, I., Delfino, C., Fina, F., Salas, S., Muracciole, X., Mancini, J., et al. (2009) · International Journal of Cancer · doi:10.1002/ijc.24568 · Cited by 35
“AM binds to and mediates its activity through the G protein-coupled receptor calcitonin receptor-like receptor/receptor activity-modifying protein-2 and -3 (CLR/RAMP2; CLR/RAMP3).(9) These functions were discovered through many physiological studies and are highlighted in knockout studies, in which AM null mice died i…”
BackgroundHiragushi, K., Wada, J., Eguchi, J., Matsuoka, T., Yasuhara, A., Hashimoto, I., Yamashita, T., Hida, K., Nakamura, Y., Shikata, K., et al. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00407.x · Cited by 36
“with receptor-activity-modifying protein 2 or 3 (RAMP2 or RAPM3) [18, 19].”
BackgroundHirsch, A. B., McCuen, R. W., Arimura, A., & Schubert, M. L. (2003) · Regulatory Peptides · doi:10.1016/s0167-0115(02)00208-2 · Cited by 36
Kawase, T., Okuda, K., Wu, C., Yoshie, H., Hara, K., & Burns, D. M. (1999) · Journal of Periodontal Research · doi:10.1111/j.1600-0765.1999.tb02237.x · Cited by 35
P2Y2receptor of MDCK cells: cloning, expression, and cell-specific signaling
Zambon, A. C., Hughes, R. J., Meszaros, J. G., Wu, J., Torres, B., Brunton, L. L., & Insel, P. A. (2000) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.2000.279.6.f1045 · Cited by 35
“, (14, 16, 17, 20, 37) have hypothesized the importance of cell-specific components in signal transduction.”
BackgroundKim, W. B., Moon, S.-O., Lee, S., Sung, M. J., Kim, S. H., & Park, S. K. (2003) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000081740.65173.d1 · Cited by 37
Nagoshi, Y., Kuwasako, K., Ito, K., Uemura, T., Kato, J., Kitamura, K., & Eto, T. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)02184-2 · Cited by 36
Trikha, S., & Jeremic, A. M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0073080 · Cited by 37
Neuroimmune regulatory networks of the airway mucosa in allergic inflammatory disease
Jean, E. E., Good, O., Inclan-Rico, J. M., Rossi, H. L., & Herbert, D. R. (2021) · Journal of Leukocyte Biology · doi:10.1002/jlb.3ru0121-023r · Cited by 34
Modulating effects of RAMPs on signaling profiles of the glucagon receptor family
Shao, L., Chen, Y., Zhang, S., Zhang, Z., Cao, Y., Yang, D., & Wang, M. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.07.028 · Cited by 34
Edvinsson, L. I. (2022) · Journal of Internal Medicine · doi:10.1111/joim.13506 · Cited by 36
Postgenomic characterization of G-protein-coupled receptors
Mertens, I., Vandingenen, A., Meeusen, T., LOOF, A. D., & Schoofs, L. (2004) · Pharmacogenomics · doi:10.1517/14622416.5.6.657 · Cited by 43
RAMP2 Influences Glucagon Receptor Pharmacology via Trafficking and Signaling
Cegla, J., Jones, B. J., Gardiner, J. V., Hodson, D. J., Marjot, T., McGlone, E. R., Tan, T. M., & Bloom, S. R. (2017) · Endocrinology · doi:10.1210/en.2016-1755 · Cited by 36
Innovative Medicine: Basic Research and Development
Nakao, K., Minato, N., & Üemoto, S. (2015) · Springer eBooks · doi:10.1007/978-4-431-55651-0 · Cited by 10
Adrenomedullin: Multiple functions in human pregnancy
Wilson, C., Nikitenko, L. L., Sargent, I. L., & REES, M. C. P. (2004) · Angiogenesis · doi:10.1007/s10456-004-4183-5 · Cited by 36
“Three RAMP proteins have been identified (RAMP1, 2 and 3) and these proteins alter the affinity of CRLR for the related peptides [16].”
BackgroundQing, X., & Keith, I. M. (2003) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00356.2002 · Cited by 34
“On the other hand, cotransfection of CRLR with RAMP2 and RAMP3 resulted in ADM receptors and mixed-type ADM/CGRP receptors, respectively (9, 13, 25, 27).”
BackgroundInfluentialOksche, A., Leder, G., Valet, S., Platzer, M., Hasse, K., Geist, S., Krause, G., Rosenthal, A., & Rosenthal, W. (2002) · Molecular Endocrinology · doi:10.1210/mend.16.4.0796 · Cited by 34
Sams, A. G., Knyihár‐Csillik, E., Engberg, J., Szok, D., Tajti, J., Bódi, I., Edvinsson, L. I., Vécsei, L., & Jansen‐Olesen, I. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00781-0 · Cited by 36
Functional Assays for Identifying Ligands at Orphan G Protein-Coupled Receptors
Szekeres, P. G. (2002) · Receptors and Channels · doi:10.3109/10606820214642 · Cited by 40
Adrenomedullin receptors in rat cerebral microvessels
Kobayashi, H., Minami, S., Yamamoto, R., Masumoto, K., Yanagita, T., Uezono, Y., Tsuchiya, K., Mohri, M., Kitamura, K., Eto, T., et al. (2000) · Molecular Brain Research · doi:10.1016/s0169-328x(00)00148-0 · Cited by 34
Divergent properties of mouse netrins
Püschel, A. W. (1999) · Mechanisms of Development · doi:10.1016/s0925-4773(99)00035-0 · Cited by 34
Cooray, S. N., Chung, T.-T., Mazhar, K., Szidonya, L., & Clark, A. J. L. (2011) · Endocrinology · doi:10.1210/en.2010-1053 · Cited by 33
Regulation and function of the CGRP receptor complex in human granulopoiesis
Harzenetter, M. D., Keller, U. B., Beer, S., Riedl, C., Peschel, C., & Holzmann, B. (2002) · Experimental Hematology · doi:10.1016/s0301-472x(02)00772-5 · Cited by 34
“Although mRNAs for RAMP-1 and CRLR were detected in multiple tissues [1,20], expression and regulation of the various CGRP receptor components in hematopoietic cells have not been characterized yet.”
BackgroundInfluentialGonzález‐Hernández, A., Marichal‐Cancino, B. A., Lozano‐Cuenca, J., López‐Canales, J. S., Muñoz‐Islas, E., Ramirez-Rosas, M. B., & Villalón, C. M. (2016) · BioMed Research International · doi:10.1155/2016/2056786 · Cited by 33
Molecular chaperones and G protein-coupled receptor maturation and pharmacology
Tao, Y. (2020) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2020.110862 · Cited by 33
Moreno‐Ajona, D., Pérez-Rodríguez, A., & Goadsby, P. J. (2020) · Medicine in Drug Discovery · doi:10.1016/j.medidd.2020.100053 · Cited by 37
Updates on Genes and Genetic Mechanisms Implicated in Primary Angle-Closure Glaucoma
Kondkar, A. A. (2021) · The Application of Clinical Genetics · doi:10.2147/tacg.s274884 · Cited by 35
Watkins, H. A., Walker, C. S., Ly, K. N., Bailey, R. J., Barwell, J., Poyner, D. R., & Hay, D. L. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12508 · Cited by 34
“The CGRP receptor is formed of a complex between CLR and RAMP1 (McLatchie et al., 1998).”
BackgroundMethodInfluentialThekkumkara, T., & Linas, S. L. (2003) · Biochemical Journal · doi:10.1042/bj20020960 · Cited by 33
Sardi, C., Zambusi, L., Finardi, A., Ruffini, F., Tolun, A. A., Dickerson, I. M., Righi, M., Zacchetti, D., Grohovaz, F., Provini, L., et al. (2014) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2014.03.008 · Cited by 35
“CLR is a high-affinity receptor for CGRP when co-expressed with RAMP1, and for adrenomedullin when co-expressed with RAMP2 or RAMP3 (McLatchie et al., 1998).”
BackgroundGangula, P. R., Chauhan, M., Reed, L. C., & Yallampalli, C. (2009) · Neuroscience Letters · doi:10.1016/j.neulet.2009.02.068 · Cited by 33
“Because the vasodilator sensitivity to CGRP and I-CGRP levels in circulation are elevated by female sex steroid hormone treatment, we next examined whether the protein expression of CRLR and RAMP1 are modulated by these hormones.”
BackgroundInfluentialMechanisms of Disease: the adrenocorticotropin receptor and disease
Clark, A. J., & Metherell, L. (2006) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0165 · Cited by 35
RAMP1 Is a Direct NKX3.1 Target Gene Up-Regulated in Prostate Cancer that Promotes Tumorigenesis
Logan, M., Anderson, P. D., Saab, S. T., Hameed, O. M., & Abdulkadir, S. A. (2013) · American Journal Of Pathology · doi:10.1016/j.ajpath.2013.05.021 · Cited by 33
Chen, Z., Liu, G., Xiao, Y., & Lu, P. (2014) · PubMed Central · Cited by 37
Adrenomedullin, a Novel Target for Neurodegenerative Diseases
Ferrero, H., Larráyoz, I. M., Gil-Bea, F. J., Martínez, A., & Ramírez, M. J. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-1031-y · Cited by 34
Xu, W., Wittchen, E. S., Hoopes, S. L., Stefanini, L., Burridge, K., & Caron, K. M. (2018) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.118.311645 · Cited by 34
Dissociation and trafficking of rat GABAB receptor heterodimer upon chronic capsaicin stimulation
Laffray, S., Tan, K. R., Dulluc, J., Bouali‐Benazzouz, R., Calver, A. R., Nagy, F., & Landry, M. (2007) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2007.05398.x · Cited by 33
“(ii) Adaptor proteins, acting as chaperones (McLatchie et al., 1998), also”
BackgroundGut Hormones as Potential New Targets for Appetite Regulation and the Treatment of Obesity
Field, B. C. T., Wren, A., Cooke, D., & Bloom, S. R. (2008) · Drugs · doi:10.2165/00003495-200868020-00002 · Cited by 38
Schorscher-Petcu, A., Austin, J., Mogil, J. S., & Quirion, R. (2009) · Journal of Molecular Neuroscience · doi:10.1007/s12031-009-9201-z · Cited by 36
“While RAMP1 is crucial for plasma membrane insertion and ligand specificity toward CGRP (McLatchie et al. 1998), RCP is required for functional coupling of CLR to a stimulatory G-protein (Evans et al. 2000).”
BackgroundKawase, T., Okuda, K., & Burns, D. M. (2005) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00504.2004 · Cited by 34
“A molecular biological approach has revealed that CGRPR1 is a heterodimer composed of the calcitonin receptor-like receptor protein (CRLR or CLR) and receptor activity-modifying protein 1 (RAMP-1) (23).”
BackgroundInfluentialCalcitonin Gene-Related Peptide (CGRP) and CGRP Receptor Expression at the Human Implantation Site
Tsatsaris, V., Couturier‐Tarrade, A., Merviel, P., Garel, J.-M., Segond, N., Jullienne, A., & Evain‐Brion, D. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020138 · Cited by 36
Calcitonin-gene related peptide (CGRP) inhibits interleukin-7-induced pre-B cell colony formation
Fernandez, S., Knopf, M. A., & McGillis, J. P. (2000) · Journal of Leukocyte Biology · doi:10.1002/jlb.67.5.669 · Cited by 34
“A neuropeptide of particular interest is ADM, whose receptor is proposed to share components with the CGRP receptor [36].”
BackgroundInfluentialIdentification of second and third calcitonin receptor-stimulating peptides in porcine brain
Katafuchi, T., Hamano, K., Kikumoto, K., & Minamino, N. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)01413-x · Cited by 33
Knockouts and transgenics confirm the importance of adrenomedullin in the vasculature
Hay, D. L., & Smith, D. M. (2001) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01617-5 · Cited by 34
Intron-mediated expression of the human neuropeptide Y Y1 receptor
Marklund, U., Byström, M., Gedda, K., Larefalk, Å., Juneblad, K., Nyström, S., & Ekstrand, A. J. (2002) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(01)00738-9 · Cited by 37
Metadata
- Authors
- McLatchie, L. M., Fraser, N. J., Main, M. J., Wise, A., Brown, J., Thompson, N., Solari, R., Lee, M. G., & Foord, S. M.
- Corresponding author
- Foord, Steven M.
- Venue
- Nature
- Published
- 1998-05
- Volume
- 393
- Issue
- 6683
- Pages
- 333-339
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2111112233
- Cited by
- 2,134
- References
- 27
- Citations by year
- 2026: 27 · 2025: 52 · 2024: 50 · 2023: 36 · 2022: 60 · 2021: 57 · 2020: 73 · 2019: 66 · 2018: 66 · 2017: 60 · 2016: 68 · 2015: 61 · 2014: 59 · 2013: 75 · 2012: 69
- FWCI
- 40.11
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Open Research (University of Surrey) (submittedVersion)
- Surrey Research Insight Open Access (The University of Surrey) (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Life Sciences › Neuroscience › Sensory Systems › Ion Channels and Receptors
- Keywords
- calcitonin receptor-like receptor, receptor activity-modifying proteins, RAMP1, RAMP2, calcitonin gene-related peptide, adrenomedullin, G protein-coupled receptors, receptor trafficking, plasma membrane transport, core glycosylation, ligand specificity, peptide receptors
- MeSH terms
- Amino Acid Sequence, Animals, Biological Transport, Calcitonin, Cell Line, Cloning, Molecular, Cross-Linking Reagents, Glycosylation, Humans, Membrane Proteins, Molecular Sequence Data, Peptides, RNA, Messenger, Tumor Cells, Cultured, Xenopus, Calcitonin Gene-Related Peptide, Gene Expression, Sequence Alignment, 3T3 Cells, Mannosyl-Glycoprotein Endo-beta-N-Acetylglucosaminidase, Receptors, Peptide, Receptors, Calcitonin, Receptors, Calcitonin Gene-Related Peptide, Cystic Fibrosis Transmembrane Conductance Regulator, Intracellular Signaling Peptides and Proteins, Mice, Adrenomedullin, Receptor Activity-Modifying Proteins, Receptor Activity-Modifying Protein 1, Receptor Activity-Modifying Protein 2, Receptors, Adrenomedullin, Calcitonin Receptor-Like Protein
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.